Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study

Authors: Roussel, Murielle ^*, Lauwers-Cances, Valérie, Macro, Margaret, Leleu, Xavier, Royer, Bruno, Hulin, Cyrille, Karlin, Lionel, Perrot, Aurore, Touzeau, Cyrille, Chrétien, Marie-Lorraine, Rigaudeau, Sophie, Dib, Mamoun, Nicolas-Virelizier, Emmanuelle, Escoffre-Barbe, Martine, Belhadj, Karim, Mariette, Clara, Stoppa, Anne-Marie, Araujo, Carla, Doyen, Chantal, Fontan, Jean, Kolb, Brigitte, Garderet, Laurent, Brechignac, Sabine, Malfuson, Jean-Valère, Jaccard, Arnaud, Lenain, Pascal, Borel, Cécile, Hebraud, Benjamin, Benbrahim, Omar, Dorvaux, Véronique, Manier, Salomon, Augeul-Meunier, Karine, Vekemans, Marie-Christiane, Randriamalala, Edouard, Chaoui, Driss, Caers, Jo, Chaleteix, Carine, Benboubker, Lofti, Vincent, Laure, Glaisner, Sylvie, Zunic, Patricia, Slama, Borhane, Eveillard, Jean-Richard, Humbrecht-Kraut, Catherine, Morel, Véronique, Mineur, Philippe, Eisenmann, Jean-Claude, Demarquette, Hélène, Richez, Valentine, Vignon, Marguerite, Caillot, Denis, Facon, Thierry, Moreau, Philippe, Colin, Anne-Laurène, Olivier, Pascale, Wuilleme, Soraya, Avet-Loiseau, Hervé, Corre, Jill, Attal, Michel

Source: In Blood 5 May 2022 139(18):2747-2757

Detection of drug safety signals from clinical trials data: Role of SUSARs

Authors: Perez, Christelle, Olivier, Pascale, Lortal, Barbara, Duranton, Sophie, Montastruc, Jean-Louis, Colin, Anne-Laurène, Toulza, Emilie, Becker, Madlyne, Hamy, Laura, Crepin, Sabrina, Roussillon, Caroline, Gimbert, Anne, Petitpain, Nadine, Salvo, Francesco

Source: In Pharmacological Research May 2018 131:218-223

Integrated analysis of randomized controlled trials evaluating bortezomib + lenalidomide + dexamethasone or bortezomib + thalidomide + dexamethasone induction in transplant-eligible newly diagnosed multiple myeloma.

Authors: Rosiñol, Laura, Hebraud, Benjamin, Oriol, Albert, Colin, Anne-Laurène, Tamayo, Rafael Ríos, Hulin, Cyrille, Blanchard, María Jesús, Caillot, Denis, Sureda, Anna, Hernandez, Miguel Teodoro, Arnulf, Bertrand, Mateos, Maria-Victoria, Macro, Margaret, San-Miguel, Jesús, Belhadj, Karim, Lahuerta, Juan Jose, Garelik, M. Brigid, Blade, Joan, Moreau, Philippe

Source: Frontiers in Oncology; 2023, p01-12, 12p

Subject Terms: MULTIPLE myeloma, THALIDOMIDE, RANDOMIZED controlled trials, BORTEZOMIB, LENALIDOMIDE

This result is not displayed to guests.
Login for full access.

Integrated Analysis of Bortezomib-Lenalidomide-Dexamethasone vs Bortezomib-Thalidomide-Dexamethasone in Transplant-Eligible Newly Diagnosed Myeloma

Authors: Rosinol, Laura, Hebraud, Benjamin, Oriol, Albert, Colin, Anne-Laurène, Tamayo, Rafael Ríos, Hulin, Cyrille, Blanchard, Maria Jesús, Caillot, Denis, Balari, Anna Sureda, Hernandez, Miguel T., Arnulf, Bertrand, Mateos, Maria-Victoria, Macro, Margaret, San-Miguel, Jesus, Belhadj, Karim, Lahuerta, Juan-Jose, Garelik, M. Brigid, Blade, Joan, Moreau, Philippe, Attal, Michel

Source: In Clinical Lymphoma, Myeloma and Leukemia October 2019 19(10) Supplement:e1-e2

This result is not displayed to guests.
Login for full access.